Ovarian cancer tends to be resistant to hormone therapy, even when it should theoretically respond. Wistar Institute ...
For more than 20 years, women entering menopause were told to be afraid of hormone replacement therapy. Headlines warned of ...
A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...
As of last month, according to the US Department of Health and Human Services, the FDA is requesting that companies remove ...
The change removes several major safety notices from common hormone products, but doctors say decisions should remain individualized.
Around the time I turned 50, my periods started to become sporadic. They’d disappear for a few months, then return with a ...
Everyday Health on MSNOpinion
Menopause advocate Tamsen Fadal on why the FDA’s hormone therapy warning shift is a turning point for women
The menopause advocate and author explains how the FDA’s decision to remove the black box warning from hormone therapies will ...
Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as ...
Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in women before age 55. Researchers discovered that women treated ...
7don MSN
Overlooked hormone may be deadly driver of postmenopausal breast cancer in women with obesity
A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be ...
More women are asking about testosterone therapy. Here’s what the science shows, the risks to know, and who may benefit from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results